BREAKING NEWS – US FDA Approves Lutetium Lu 177 dotatate (Lutathera®) – PRRT?

26Jan 2018 by Ronny Allan 4 Comments

PRRT was approved in USA on 26 Jan 2018. The approval is for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors in adults. CLICK HERE.

The extended access program (trial) is no longer offered but these locations should be ahead of the game in terms of provision, notwithstanding insurance and provision of sufficient nuclear material.

Read more about PRRT by clicking here

Thanks for reading

I’m also active on Facebook. Like my page for even more news. I’m also building up this site here: Ronny Allan

My Diagnosis and Treatment History

Most Popular Posts

Sign up for my twitter newsletter

Remember ….. in the war on Neuroendocrine Cancer, let’s not forget to win the battle for better quality of life!

Please Share this post

Related

Discover more from Ronny Allan - Living with Neuroendocrine Cancer

Subscribe to get the latest posts to your email.

4 thoughts on “BREAKING NEWS – US FDA Approves Lutetium Lu 177 dotatate (Lutathera®) – PRRT?”

#ChronicIllness Morning Post: A selection of online health related newspapers/magazines… – FibroFlutters – Support Group Website

[…] Ronny’s latest post – BREAKING NEWS – US FDA Approves Lutetium Lu 177 dotatate (Lutathera®) – PRRT? […]

Loading...

January 29, 2018 at 09:19
Reply
Tony Mc Grory

Positive Reinforcement – Required Treatment

https://polldaddy.com/js/rating/rating.js

Loading...

January 26, 2018 at 21:10
Reply
- Ronny Allan
  
  😊
  
  Loading...
  
  January 26, 2018 at 22:23
  Reply
grantsviews

Excellent research Ronny. Getting a global view of the current status will be very helpful to any folks unable to receive the PRRT in their homeland.
Big Thankyou for your continued efforts and sharing data as you receive it!!!

https://polldaddy.com/js/rating/rating.js

Loading...

January 26, 2018 at 19:35
Reply

I love comments - feel free!Cancel reply

‘Chinese Dumplings’ and Neuroendocrine Cancer

Update of one of my posts from 2015 which was interesting in that year. This is not really about a treatment which is available everywhere but was a novel approach by one of the world’s most gifted and innovative NET surgeons. Please note this is not a nutrition post! One of my daily alerts brought […]

“An odd disposition of tumours” – less common metastases in Small Intestine and Pancreatic NETs

Every day is a learning day in NET! When I was diagnosed in 2010, my Oncologist sent me for a specialist scan that would help confirm my staging definition and to document anything that might not have shown up on CT. This was described as an Octreotide Scan (somatostatin receptor scintigraphy) (now mostly replaced by […]

Chemotherapy for Neuroendocrine Cancer

Edited and checked April 2024 One of the unusual aspects of Neuroendocrine Cancer is that chemotherapy is not normally considered as a ‘standard of care’ or first-line treatment, unlike many other cancers. One exception is high grade (Grade 3) where it is very often a first and/or second-line therapy. This is particularly the case with […]

Carcinoid vs Neuroendocrine

OPINION – There’s a constant debate regarding the validity of the term ‘Carcinoid‘. I’ve posted about this a few times and as far as I know, the debate has been raging for some years. This post was originally generated in April 2015 (and hasn’t changed that much!). EDIT MARCH 2024. There is now a consolidated Endocrine/Neuroendoceine […]

Things are not always how they seem

Graphic courtesy of SoBadAss.me (Sam Cleasby) In 2014, Chris and I walked 84 miles along Hadrian’s Wall on the English/Scottish border. It was a fantastic experience, and we met some really interesting people on our 6-day journey. On the 4th night, I encountered a lady who was pretty rude. I wanted to say something, but I […]